Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Blueprint Medicines Corp (BPMC)

Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Blueprint Medicines: Q1 Earnings Snapshot

Blueprint Medicines: Q1 Earnings Snapshot

BPMC : 103.00 (+1.76%)
Blueprint Medicines: Q4 Earnings Snapshot

Blueprint Medicines: Q4 Earnings Snapshot

BPMC : 103.00 (+1.76%)
Blueprint Stock Soars 18% on Encouraging 2025 Growth Strategy

Shares of Blueprint Medicines BPMC rallied 18.2% on Monday driven by investor enthusiasm following the company’s announcement of its 2025 corporate outlook and growth strategy, highlighting plans to...

CTMX : 2.06 (-3.29%)
CSTL : 16.50 (+0.61%)
BPMC : 103.00 (+1.76%)
HALO : 53.45 (+0.29%)
Insider Sale: PRINCIPAL ACCOUNTING OFFICER of $BPMC (BPMC) Sells 1,200 Shares

Ariel Hurley, the PRINCIPAL ACCOUNTING OFFICER of $BPMC ($BPMC), sold 1,200 shares of the company on 12-12-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately...

BPMC : 103.00 (+1.76%)
Insider Sale: CHIEF OPERATING OFFICER of $BPMC (BPMC) Sells 2,274 Shares

Christina Rossi, the CHIEF OPERATING OFFICER of $BPMC ($BPMC), sold 2,274 shares of the company on 11-27-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 3.1%...

BPMC : 103.00 (+1.76%)
Blueprint Medicines: Q3 Earnings Snapshot

Blueprint Medicines: Q3 Earnings Snapshot

BPMC : 103.00 (+1.76%)
Zacks Industry Outlook Highlights Exelixis, Blueprint Medicines, CRISPR, Amicus and Verona Pharma

For Immediate ReleaseChicago, IL – October 25, 2024 – Today, Zacks Equity Research discusses Exelixis, Inc, EXEL, Blueprint Medicines BPMC, CRISPR Therapeutics CRSP, Amicus Therapeutics FOLD and Verona...

FOLD : 6.59 (+2.65%)
CRSP : 39.25 (+1.47%)
VRNA : 74.73 (+2.96%)
EXEL : 44.36 (-0.74%)
BPMC : 103.00 (+1.76%)
5 Biotech Stocks Likely to Outperform as Industry Prospects Look Bright

It has been a decent year for the biotech industry so far, buoyed by new drug approvals and positive regulatory/pipeline updates. The third-quarter earnings season has just kicked off, with most major...

FOLD : 6.59 (+2.65%)
CRSP : 39.25 (+1.47%)
VRNA : 74.73 (+2.96%)
EXEL : 44.36 (-0.74%)
BPMC : 103.00 (+1.76%)
Blueprint Medicines: Q2 Earnings Snapshot

Blueprint Medicines: Q2 Earnings Snapshot

BPMC : 103.00 (+1.76%)
Blueprint Medicines: Q1 Earnings Snapshot

Blueprint Medicines: Q1 Earnings Snapshot

BPMC : 103.00 (+1.76%)

Barchart Exclusives

Should You Buy This Dividend-Paying Silver Stock Now?
With silver prices surging to multi-year highs, Pan American Silver’s recent acquisition and strong financials make it a compelling buy for investors seeking both growth and regular dividend income. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar